Market revenue in 2024 | USD 13.0 million |
Market revenue in 2030 | USD 26.4 million |
Growth rate | 12.5% (CAGR from 2025 to 2030) |
Largest segment | Exocrine |
Fastest growing segment | Endocrine |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Exocrine, Endocrine |
Key market players worldwide | Accuray Inc, AstraZeneca PLC ADR, Novartis AG ADR, Pfizer Inc., F. Hoffmann-La Roche Ltd., Bristol-Myers Squibb Company, Ipsen Pharma, Eli Lilly and Co, Siemens Healthineers AG ADR, Elekta AB ADR |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pancreatic cancer treatment market will help companies and investors design strategic landscapes.
Exocrine was the largest segment with a revenue share of 88.46% in 2024. Horizon Databook has segmented the UAE pancreatic cancer treatment market based on exocrine, endocrine covering the revenue growth of each sub-segment from 2018 to 2030.
The competitive landscape of the pancreatic cancer treatment market in the UAE is evolving as the incidence of pancreatic cancer continues to rise in the region. The UAE’s healthcare system is responding to the growing demand for pancreatic cancer treatments with investments in advanced oncology infrastructure and a shift toward personalized medicine.
The country is increasingly adopting innovative therapies such as immunotherapies and targeted treatments, particularly in private hospitals and specialized cancer centers in cities such as Dubai and Abu Dhabi.
The use of precision medicine is also gaining traction, with genetic profiling becoming more common in the development of personalized treatment plans for pancreatic cancer patients.
Horizon Databook provides a detailed overview of country-level data and insights on the UAE pancreatic cancer treatment market , including forecasts for subscribers. This country databook contains high-level insights into UAE pancreatic cancer treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account